title: Herpesvirus-induced diseases: oral manifestations and current treatment options.
abstract: The dentist is often the first health professional to be contracted by patients who develop acute orofacial symptoms of viral conditions such as shingles (varicella zoster) or herpetic gingivostomatitis. The diagnosis, treatment, and management of virally induced oral diseases is a challenge inasmuch as their presentation is atypical and may be complicated by immunosuppression. However, an increasing body of knowledge regarding the manifestations of viral infections in immunocompromised patients and the advances achieved in antiviral drug therapy during the past several years should make the task less daunting for the dentist. In this paper, the natural history, typical and atypical oral manifestations, diagnosis, current treatment options, and advances in the prevention of common herpesvirus-induced diseases are reviewed, with particular attention to primary and recurrent varicella zoster virus and herpes simplex type 1 infections.
authors.affiliation: Faculty of Dentistry, University of Manitoba, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Birek
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D002985:Clinical Protocols; D004892:Erythema Multiforme / Q000821:virology; D006562:Herpes Zoster / Q000175:diagnosis / Q000503:physiopathology; D006566:Herpesviridae Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D016867:Immunocompromised Host; D009059:Mouth Diseases / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology*; D012008:Recurrence; D013281:Stomatitis, Aphthous / Q000821:virology; D013283:Stomatitis, Herpetic / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D000998:Antiviral Agents